Cargando…
Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
The atypical C-X-C chemokine receptor 7 (CXCR7) has been implicated in supporting aggressive cancer phenotypes in several cancers including prostate cancer. However, the mechanisms driving overexpression of this receptor in cancer are poorly understood. This study investigates the role of androgen r...
Autores principales: | Hoy, James J., Kallifatidis, Georgios, Smith, Diandra K., Lokeshwar, Bal L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465216/ https://www.ncbi.nlm.nih.gov/pubmed/28596572 http://dx.doi.org/10.1038/s41598-017-02918-3 |
Ejemplares similares
-
The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation
por: Salazar, Nicole, et al.
Publicado: (2014) -
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
por: Korbecki, Jan, et al.
Publicado: (2021) -
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
por: Nagaya, Naoya, et al.
Publicado: (2020) -
Targeting Mitochondrial Metabolism in Prostate Cancer with Triterpenoids
por: Mamouni, Kenza, et al.
Publicado: (2021) -
CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis
por: Gharaee-Kermani, Mehrnaz, et al.
Publicado: (2012)